Skip to main content
Premium Trial:

Request an Annual Quote

Golden Helix Appoints Filgen its Distributor in Japan

NEW YORK (GenomeWeb News) – Bioinformatics firm Golden Helix today announced it has set up an office in Japan and appointed Filgen its exclusive distributor in the region.

Filgen will work directly with Golden Helix, headquartered in Bozeman, Mont., to market and support its SNP & Variation Suite, a software package for analyzing SNPs, copy number, and next-generation sequencing data.

Terms of the deal were not disclosed.

"Having a local office will help Golden Helix take up a strong position in this important market by showing its commitment to this extremely demanding customer base," David Leangen, the newly appointed country manager for Golden Helix Japan.

Filgen is based in Nagoya, Japan and develops, manufactures, and sells science research equipment and provides analysis services to the life sciences market.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.